NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling

Por Freire, Pablo R., Conneely, Orla M.
Publicado no Blood (2018)

Single-cell analysis of transcription kinetics across the cell cycle

Por Skinner, Samuel O, Xu, Heng, Nagarkar-Jaiswal, Sonal, Freire, Pablo R, Zwaka, Thomas P, Golding, Ido
Publicado no eLife (2016)

Exposing the cancer genome atlas as a SPARQL endpoint

Por Deus, Helena F., Veiga, Diogo F., Freire, Pablo R., Weinstein, John N., Mills, Gordon B., Almeida, Jonas S.
Publicado em 2010

Drug Targeting of NR4A Nuclear Receptors for Treatment of Acute Myeloid Leukemia

Por Boudreaux, Seth P., Duren, Ryan P., Call, Steven G., Nguyen, Loc, Freire, Pablo R, Narayanan, Padmini, Redell, Michele S., Conneely, Orla M.
Publicado no Leukemia (2018)

Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors

Por Call, S. Greg, Duren, Ryan P., Panigrahi, Anil K., Nguyen, Loc, Freire, Pablo R., Grimm, Sandra L., Coarfa, Cristian, Conneely, Orla M.
Publicado no Sci Rep (2020)

Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis

Por Kim, Yong-Wan, Koul, Dimpy, Kim, Se Hoon, Lucio-Eterovic, Agda Karina, Freire, Pablo R., Yao, Jun, Wang, Jing, Almeida, Jonas S., Aldape, Ken, Yung, W.K. Alfred
Publicado em 2013